The splicing factor SMNDC1 facilitates alternative RNA splicing, contributing to therapy resistance in pancreatic cancer

被引:0
|
作者
Siraj, Md Afjalus
Zhang, Yushan
Yugawa, Deanne
Giri, Gilbert
Chakraborty, Prabir
Goda, Grant
Rao, Geeta
Dominguez, Daniel
Kubicek, Stefan
Bhattacharya, Resham
Escobar-Hoyos, Luisa
Mukherjee, Priyabrata
机构
关键词
D O I
10.1158/1538-7445.PANCREATIC24-B083
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B083
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancer
    Lee, Ahn R.
    Gan, Yu
    Xie, Ning
    Ramnarine, Varune R.
    Lovnicki, Jessica M.
    Dong, Xuesen
    CANCER SCIENCE, 2019, 110 (01): : 245 - 255
  • [42] The role of alternative splicing in cancer: From oncogenesis to drug resistance
    Sciarrillo, Rocco
    Wojtuszkiewicz, Anna
    Assaraf, Yehuda G.
    Jansen, Gerrit
    Kaspers, Gertjan J. L.
    Giovannetti, Elisa
    Cloos, Jacqueline
    DRUG RESISTANCE UPDATES, 2020, 53
  • [43] Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer
    Yu, Shiyi
    Wu, Rui
    Si, Yue
    Fan, Zhehao
    Wang, Ying
    Yao, Chang
    Sun, Rongmao
    Xue, Yaji
    Chen, Yongli
    Wang, Zheng
    Dong, Shuangshuang
    Wang, Ning
    Ling, Xinyue
    Liang, Zhengyan
    Bi, Caili
    Yang, Yi
    Dong, Weibing
    Sun, Haibo
    ONCOGENE, 2024, 43 (39) : 2901 - 2913
  • [44] Identification of an alternative splicing signature as an independent factor in colon cancer
    Chen, Haitao
    Luo, Jun
    Guo, Jianchun
    BMC CANCER, 2020, 20 (01)
  • [45] Identification of an alternative splicing signature as an independent factor in colon cancer
    Haitao Chen
    Jun Luo
    Jianchun Guo
    BMC Cancer, 20
  • [46] Perspectives of RNA interference application in the therapy of diseases associated with defects in alternative RNA splicing
    Wysokinski, Daniel
    Blasiak, Janusz
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2012, 66 : 683 - 695
  • [47] Integrative RNA-omics Discovers GNAS Alternative Splicing as a Phenotypic Driver of Splicing Factor-Mutant Neoplasms
    Wheeler, Emily C.
    Vora, Shailee
    Mayer, Daniel
    Kotini, Andriana G.
    Olszewska, Malgorzata
    Park, Samuel S.
    Guccione, Ernesto
    Teruya-Feldstein, Julie
    Silverman, Lewis
    Sunahara, Roger K.
    Yeo, Gene W.
    Papapetrou, Eirini P.
    CANCER DISCOVERY, 2022, 12 (03) : 836 - 855
  • [48] Opportunities and methods for studying alternative splicing in cancer with RNA-Seq
    Feng, Huijuan
    Qin, Zhiyi
    Zhang, Xuegong
    CANCER LETTERS, 2013, 340 (02) : 179 - 191
  • [49] Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy
    Mehterov, Nikolay
    Kazakova, Maria
    Sbirkov, Yordan
    Vladimirov, Boyan
    Belev, Nikolay
    Yaneva, Galina
    Todorova, Krassimira
    Hayrabedyan, Soren
    Sarafian, Victoria
    GENES, 2021, 12 (07)
  • [50] Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy
    Deng, Kun
    Yao, Jingwei
    Huang, Jialu
    Ding, Yubo
    Zuo, Jianhong
    TRANSLATIONAL ONCOLOGY, 2021, 14 (06):